Literature DB >> 16636588

Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin.

Jai Wong Chang1, Choung Soo Kim, Soon Bae Kim, Su Kil Park, Jung Sik Park, Sang Koo Lee.   

Abstract

BACKGROUND: It is not fully understood whether intracellular calcium and/or reactive oxygen species (ROS) are involved in nuclear factor-kappaB (NF-kappaB) activation by proinflammatory cytokines. Silymarin exhibits anti-inflammatory and antioxidant effects but the effect of silymarin in human mesangial cells is largely unknown.
METHOD: NF-kappaB binding activity was measured by electrophoretic mobility shift assay. Intracellular calcium was monitored by confocal microscopy using Fluo-3 and intracellular ROS production was determined by flow cytometry. Monocyte chemoattractant protein-1 (MCP-1) expression was measured by Northern blot analysis and ELISA.
RESULTS: NF-kappaB was activated within 30 min by tumor necrosis factor-alpha (TNF-alpha) or interleukin-1beta (IL-1beta). Intracellular ROS was not produced until 30 min and also antioxidants such as N-acetylcysteine and tiron had no effect on the TNF-alpha- or IL-1beta-induced NF-kappaB activation. Intracellular calcium was increased by TNF-alpha and IL-1beta. Furthermore, a calcium chelator, BAPTA-AM, attenuated the NF-kappaB activation. Silymarin dose-dependently inhibited the TNF-alpha- or IL-1beta-induced NF-kappaB activation and MCP-1 expression. Silymarin also inhibited TNF-alpha-induced intracellular calcium.
CONCLUSIONS: Induction of NF-kappaB within 30 min by TNF-alpha- and IL-1beta was mediated through intracellular calcium but not ROS. Silymarin inhibited TNF-alpha-induced calcium-dependent NF-kappaB activation irrespective of its antioxidant effect. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636588     DOI: 10.1159/000092906

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  6 in total

1.  Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells.

Authors:  Chanyu Yue; Jonathan Soboloff; Ana M Gamero
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Soy protein prevents renal damage in a fructose-induced model of metabolic syndrome via inhibition of NF-kB in male rats.

Authors:  Nallasamy Palanisamy; Carani Venkataraman Anuradha
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

3.  Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6.

Authors:  Katia Azarfar; Parichehreh Yaghmaei; Mahsa M Amoli; Nasim Hayati-Roodbari; Azadeh Ebrahim-Habibi
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

Review 4.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

5.  Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney.

Authors:  Hakan Senturk; Sahin Kabay; Gokhan Bayramoglu; Hilmi Ozden; Faik Yaylak; Mehmet Yucel; Esra Gurlek Olgun; Ali Kutlu
Journal:  World J Urol       Date:  2008-04-12       Impact factor: 4.226

6.  Inhibition of ERK1/2 by silymarin in mouse mesangial cells.

Authors:  Cha Kyung Youn; Sung Il Cho; Min Young Lee; Young Jin Jeon; Seog Ki Lee
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.